FDMT
Price
$10.81
Change
+$0.72 (+7.14%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
617.63M
99 days until earnings call
Intraday BUY SELL Signals
TNGX
Price
$8.29
Change
+$0.28 (+3.50%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.11B
130 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FDMT vs TNGX

Header iconFDMT vs TNGX Comparison
Open Charts FDMT vs TNGXBanner chart's image
4D Molecular Therapeutics
Price$10.81
Change+$0.72 (+7.14%)
Volume$25.87K
Capitalization617.63M
Tango Therapeutics
Price$8.29
Change+$0.28 (+3.50%)
Volume$70.31K
Capitalization1.11B
FDMT vs TNGX Comparison Chart in %
FDMT
Daily Signal:
Gain/Loss:
TNGX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FDMT vs. TNGX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and TNGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (FDMT: $10.81 vs. TNGX: $8.28)
Brand notoriety: FDMT and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 103% vs. TNGX: 100%
Market capitalization -- FDMT: $617.63M vs. TNGX: $1.11B
FDMT [@Biotechnology] is valued at $617.63M. TNGX’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 0 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 0 green, 5 red.
According to our system of comparison, TNGX is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 3 TA indicator(s) are bullish while TNGX’s TA Score has 3 bullish TA indicator(s).

  • FDMT’s TA Score: 3 bullish, 5 bearish.
  • TNGX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, FDMT is a better buy in the short-term than TNGX.

Price Growth

FDMT (@Biotechnology) experienced а -1.46% price change this week, while TNGX (@Biotechnology) price change was +7.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

FDMT is expected to report earnings on Feb 27, 2026.

TNGX is expected to report earnings on Mar 30, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNGX($1.11B) has a higher market cap than FDMT($618M). TNGX YTD gains are higher at: 167.961 vs. FDMT (94.075). TNGX has higher annual earnings (EBITDA): -154.8M vs. FDMT (-213.2M). FDMT has more cash in the bank: 293M vs. TNGX (181M). FDMT has less debt than TNGX: FDMT (23.1M) vs TNGX (35M). TNGX has higher revenues than FDMT: TNGX (24.3M) vs FDMT (33K).
FDMTTNGXFDMT / TNGX
Capitalization618M1.11B55%
EBITDA-213.2M-154.8M138%
Gain YTD94.075167.96156%
P/E RatioN/AN/A-
Revenue33K24.3M0%
Total Cash293M181M162%
Total Debt23.1M35M66%
TECHNICAL ANALYSIS
Technical Analysis
FDMTTNGX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 27 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FDMT
Daily Signal:
Gain/Loss:
TNGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGRCX13.73N/A
N/A
Goldman Sachs Strategic Growth C
GCVIX25.16N/A
N/A
Goldman Sachs Large Cp Val Insghts Instl
PINTX11.82N/A
N/A
Principal Overseas R3
IDPIX74.11N/A
N/A
ProFunds Industrial Ultra Sector Inv
PREJX27.13N/A
N/A
Principal Real Estate Securities J

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+7.14%
RGNX - FDMT
46%
Loosely correlated
-2.84%
IMTX - FDMT
43%
Loosely correlated
N/A
CLDX - FDMT
42%
Loosely correlated
-2.58%
IDYA - FDMT
42%
Loosely correlated
-1.72%
RCUS - FDMT
42%
Loosely correlated
+0.15%
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with CLDX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
+3.50%
CLDX - TNGX
42%
Loosely correlated
-2.58%
XNCR - TNGX
42%
Loosely correlated
-1.62%
FDMT - TNGX
42%
Loosely correlated
+7.14%
AXON - TNGX
41%
Loosely correlated
-0.50%
RCUS - TNGX
39%
Loosely correlated
+0.15%
More